-
FEASIBILITY ASSESSMENT OF UNANCHORED INDIRECT TREATMENT COMPARISON OF ASCIMINIB VERSUS SECOND-GENERATION TKIS IN SECOND-LINE SETTING FOR PATIENTS WITH CHRONIC MYELOID LEUKAEMIA
Aug 11, 2026, 17:16 PM -
DEVELOPING AN EVIDENCE RECOMMENDATIONS LIBRARY FOR DIGITAL HEALTH TECHNOLOGIES: A PRAGMATIC REVIEW OF NICE HEALTHTECH GUIDANCE
Aug 11, 2026, 17:16 PM -
APPLICATION OF A MULTI-CRITERIA DECISION ANALYSIS FRAMEWORK FOR THE OPTIMISATION OF A COMPLEX PARENTING INTERVENTION IN SOUTHEAST EUROPE: A COST-CONSEQUENCES ANALYSIS OF THE FLOURISH FACTORIAL TRIAL
Aug 11, 2026, 17:16 PM -
BEYOND MAIC: LEVERAGING ML-NMR FOR PARAMETRIC SURVIVAL EXTRAPOLATION IN INDIRECT TREATMENT COMPARISONS
Aug 11, 2026, 17:16 PM -
WHEN BIOMARKERS EVOLVE FASTER THAN PICOS: EVIDENCE-BASED JCA MAPPING IN KRAS-MUTATED NON-SMALL CELL LUNG CANCER (NSCLC) USING REAL-SLR
Aug 11, 2026, 17:16 PM -
BASELINE-STRATIFIED MCID ESTIMATES AND RESPONDER CLASSIFICATION AFTER KNEE ARTHROPLASTY REHABILITATION IN AUSTRIA
Aug 11, 2026, 17:16 PM -
DURATION-CONSCIOUS TARGET TRIAL EMULATION VIA G-ESTIMATION OF STRUCTURAL NESTED MEAN MODELS
Aug 11, 2026, 17:16 PM -
BUDGET IMPACT ANALYSIS OF PERIOPERATIVE PEMBROLIZUMAB PLUS STANDARD OF CARE AS TREATMENT FOR RESECTABLE LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA IN THE UNITED STATES
Aug 11, 2026, 17:16 PM -
COUNTING THE COST: MEASURING ADMINISTRATIVE BURDEN IN EU JOINT CLINICAL ASSESSMENT
Aug 11, 2026, 17:16 PM -
INDIRECT TREATMENT COMPARISONS IN UK HTA: WHEN ARE THEY ACCEPTED AND HOW DO THEY SHAPE VALUE PERCEPTIONS?
Aug 11, 2026, 17:16 PM -
MAKING THE BEST OUT OF AVAILABLE REGULATED PRICE OPTIONS FOR MEDICINAL PRODUCTS (MPS) FOR HUMAN USE IN SLOVENIA: EXCEPTIONAL HIGHER ALLOWED PRICE (EHAP) AND INVISIBLE MAXIMUM ALLOWED PRICE (IMAP)
Aug 11, 2026, 17:16 PM -
PICO PROVENANCE EVALUATING AI TRACEABILITY FOR EU JOINT CLINICAL ASSESSMENTS
Aug 11, 2026, 17:16 PM -
HEALTH STATE UTILITIES FOR CLINICAL EVENTS IN ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW
Aug 11, 2026, 17:16 PM -
MULTIDISCIPLINARY ASSESSMENT OF HEALTHCARE PROFESSIONALS' ADOPTION WILLINGNESS, BARRIERS, AND FACILITATORS FOR DUCHENNE MUSCULAR DYSTROPHY GENE THERAPY IN SPAIN
Aug 11, 2026, 17:16 PM -
ONLINE PROBLEM GAMBLING AMONG YOUNG ADULTS IN GREECE
Aug 11, 2026, 17:16 PM -
PAN-EUROPEAN EVIDENCE OF ROBOTIC-ASSISTED SURGERY USING THE DA VINCI SURGICAL SYSTEM FOR BENIGN PROCEDURES: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS
Aug 11, 2026, 17:16 PM -
LEVERAGING AI PLATFORMS TO ANTICIPATE EU JCA DOSSIER RISKS: INSIGHTS FROM EARLY TERMINATIONS
Aug 11, 2026, 17:16 PM -
DUPILUMAB REDUCES EXACERBATIONS WHILE IMPROVING LUNG FUNCTION AND QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND TYPE 2 INFLAMMATION, REGARDLESS OF SMOKING STATUS
Aug 11, 2026, 17:16 PM -
BURDEN OF CLOSTRIDIOIDES DIFFICILE INFECTION (CDI) IN PATIENTS AT HIGH RISK OF RECURRENCE IN SPAIN
Aug 11, 2026, 17:16 PM -
PROSTATIC HEALTH AND QUALITY OF LIFE ASSESSMENT: UNDERSTANDING SYMPTOMS AND IMPACT OF PROSTATIC CONDITIONS
Aug 11, 2026, 17:16 PM
